Federal funding for biomedical research has fallen 22 percent since 2003, dramatically slowing the pace of development for new drugs and treatments. A hoped-for remedy is the 21st Century Cures Act, which would set funding levels and speed drug approvals, according to a North Texas panel of doctors and elected officials address. (Dallas Business Journal)
Madlin Mekelburg was a reporting fellow for the Tribune in 2015 and 2016. She is a graduate of the University of Texas at Austin, where she studied journalism and French. Madlin previously worked at the... More by Madlin Mekelburg
